The reduction or inhibition of immune function through multiple mechanisms including glucocorticoid signaling, sympathetic activation, T regulatory cell expansion, and metabolic reprogramming. Immune suppression exists on a spectrum: adaptive (preventing autoimmune disease, enabling tolerance) or pathological (increasing infectious disease and cancer susceptibility). In cPNI, distinguished from Selective resistance where glucocorticoid receptors become resistant to anti-inflammatory signaling while maintaining immunosuppressive effects, creating the dangerous combination of reduced cellular immunity with persistent chronic inflammation.
Imagine a factory with two security systems: the guard patrol (cellular immunity—T cells, NK cells) and the alarm system (inflammation). Normal stress is like telling both systems "stand down, we're doing renovations"—guards take a break, alarms are silenced. Everything calms.
But chronic stress creates a bizarre malfunction: the guards receive the "stand down" message loud and clear and abandon their posts (immunosuppression). Meanwhile, the alarm system's receiver breaks—it stops hearing the "stand down" signal and keeps blaring (chronic inflammation through glucocorticoid resistance). Now you have the worst of both worlds: burglars (viruses, cancer cells) walk in unchallenged while the alarm screams uselessly. The night-shift supervisor (sympathetic nervous system) makes it worse by permanently reassigning the few remaining guards from active patrol (Th1) to paperwork duty (Th2 shift). This is the selective resistance paradox—suppressed protection, persistent inflammation.
Glucocorticoid-mediated suppression:
- Cortisol binds cytoplasmic Glucocorticoid Receptor (GR)
- GR-cortisol complex translocates to nucleus
- GR binds glucocorticoid response elements (GREs) → upregulates IκB → sequesters NF-κB → prevents transcription of IL-1, IL-6, TNF-α, IL-12
- GR directly represses NF-ÎşB and AP-1 transcription factors through protein-protein interaction (transrepression)
- Induces T cell apoptosis via upregulation of pro-apoptotic genes (Bim, PUMA)
- Suppresses antigen presentation: downregulates MHC Class II, CD86 co-stimulation on dendritic cells
- Reduces GLUT1 expression on T cells → impairs glucose uptake → blocks T cell activation and proliferation
- Threshold: immunosuppression clinically significant at >20mg prednisone equivalent daily
Sympathetic nervous system suppression:
- Noradrenaline and adrenaline bind β2-adrenergic receptor on lymphocytes and macrophages
- β2-AR → PKA → CREB activation
- CREB upregulates IL-10, downregulates IL-12
- Result: Th2 shift (antibody-mediated immunity) at expense of Th1 (cellular immunity against viruses, intracellular pathogens, cancer)
- Suppresses NK cells cytotoxicity via reduced perforin/granzyme expression
- Elevates salivary Amylase (>60 U/mL indicates sympathetic dominance)
- Reduces sIgA production (<25 mg/dL = mucosal immune suppression)
- Lowers salivary pH (<6.8 indicates sympathetic dominance, reduced buffering)
Regulatory T cell-mediated suppression:
- T regulatory cells (CD4+CD25+FoxP3+) expand during chronic stress
- Tregs release IL-10 → suppresses dendritic cell maturation, reduces MHC Class II expression
- Tregs release TGF-beta → inhibits T effector cell proliferation, induces T cell anergy
- Direct cell contact: CTLA-4 on Tregs binds B7-2 on APCs → outcompetes CD28 → blocks co-stimulation
- Adaptive when preventing autoimmunity; pathological when enabling cancer immune evasion
Metabolic reprogramming:
- Chronic stress → sustained cortisol → insulin resistance → reduced GLUT1 on T cells
- T cell activation requires aerobic glycolysis (Warburg effect)
- Glucose restriction → failed mTORC1 activation → T cells cannot transition from naïve to effector state
- Reduced ATP production → insufficient energy for cytokine synthesis, clonal expansion
graph TD
A[Chronic Stress] --> B[Sustained Cortisol]
A --> C[Sympathetic Activation]
B --> D[GR Activation]
D --> E["NF-ÎşB Inhibition"]
E --> F["↓ Pro-inflammatory Cytokines"]
D --> G[T Cell Apoptosis]
D --> H["↓ Antigen Presentation"]
D --> I["↓ GLUT1 on T Cells"]
I --> J[Metabolic Suppression]
C --> K["β2-AR Stimulation"]
K --> L[Th2 Shift]
K --> M["↓ NK Cell Function"]
K --> N["↓ sIgA"]
B --> O[Selective Resistance Development]
O --> P[Maintains Immunosuppression]
O --> Q[Loses Anti-inflammatory Effect]
F --> R[Reduced Cellular Immunity]
G --> R
H --> R
J --> R
L --> R
M --> R
N --> R
R --> S["↑ Infection Risk"]
R --> T["↑ Cancer Risk"]
R --> U[Vaccine Hyporesponse]
Q --> V[Chronic Inflammation Persists]
Selective resistance mechanism:
- chronic stress → GR phosphorylation at Ser226 → impaired GR nuclear translocation for anti-inflammatory genes
- Simultaneously, GR retains ability to induce apoptosis genes (maintained immunosuppression)
- Result: cytokine resistance for IL-6, TNF-α (they stay elevated) but T cells still die off
- Creates "Selective resistance" phenotype: high inflammatory markers + frequent infections
Target populations:
- Chronic stress patients: elevated hair cortisol (>10 pg/mg), low HRV (<50ms RMSSD)
- Post-traumatic stress, chronic caregivers, chronic pain syndromes
- Athletes with overtraining syndrome (paradoxical infections despite "fitness")
- Patients with recurrent viral reactivation (EBV, herpes)
- Cancer survivors with poor immune surveillance
- Elderly with immunosenescence accelerated by stress
Metamodel connections:
- Metamodel 1 (Chronic Stress): Sustained HPA axis activation drives cortisol-mediated suppression
- Metamodel 2 (Inflammation): Selective resistance creates inflammation without protection
- Metamodel 5 (Evolutionary Mismatch): Chronic psychological stress mimics chronic infection signal—immune system deprioritizes surveillance
- Selfish Brain: Brain prioritizes glucose for itself → limits glucose to immune cells → immunometabolic failure
- Selfish Immune System: During active inflammation, immune system is "selfish"; during suppression, other systems dominate resource allocation
Clinical biomarkers:
- Salivary cortisol awakening response: blunted (<2.5 nmol/L increase) or exaggerated (>10 nmol/L) both pathological
- sIgA: <25 mg/dL = mucosal immune suppression
- Salivary pH: <6.8 = sympathetic dominance
- Salivary Amylase: >60 U/mL = sympathetic dominance
- Neutrophil-lymphocyte ratio: >3.0 suggests stress-induced immune dysregulation
- NK cell activity: <10% lysis at 25:1 effector:target ratio = functional suppression
- Vaccine response: <4-fold antibody titer increase post-vaccination = hyporesponse
Intervention implications:
- Address root Stress Axis Desynchronization: do NOT simply add adaptogens (may worsen if glucocorticoid resistance present)
- Restore vagus nerve tone: HRV biofeedback, cold exposure, singing (target >60ms RMSSD)
- Metabolic support: ensure T cell glucose availability—timed carbohydrate around immune challenges
- Resolve chronic inflammation first (SPMs, omega-3, address LPS exposure) before expecting immune restoration
- Sleep optimization: deep sleep restores cortisol rhythm and T cell priming (target >90 min deep sleep)
- Micronutrient repletion: Vitamin D (>40 ng/mL), Zinc (serum >90 ÎĽg/dL), Selenium (>120 ÎĽg/L)
- Avoid further immune suppression: cautious use of NSAIDs, corticosteroid creams, chronic antibiotic exposure
Special consideration—sexual activity immune suppression:
- Programmed Th2 shift occurs in sexually active women (up to 140% reduction in Th1 during menses-ovulation)
- Adaptive for seminal tolerance and conception
- Explains increased UTI, yeast infections in sexually active women
- Not pathological—evolutionary adaptation (sperm are foreign antigens)
Hypochondriasis paradox:
- Anxiety about health creates sympathetic dominance → immune suppression → actual increased respiratory disease mortality
- Nocebo-mediated immune suppression: belief in illness activates stress axes → self-fulfilling prophecy
- Chronic stress suppresses cellular immunity (Th1, NK cells, CTLs) while often maintaining or increasing inflammatory cytokine production through selective glucocorticoid resistance
- Threshold for pharmacological immunosuppression: approximately 20mg prednisone equivalent daily or cumulative dose >700mg over weeks
- Low salivary pH (<6.8), high amylase (>60 U/mL), and low sIgA (<25 mg/dL) form the "stress triad" indicating sympathetic dominance and mucosal immune suppression
- conditioned immunosuppression can reduce immune function 30-50% through learned neural pathways—demonstrating CNS control over immunity without conscious awareness
- Sexual activity induces programmed Th2 shift (up to 140% reduction in Th1 responses during fertile window) to enable seminal tolerance—adaptive suppression for conception
- Cortisol peaks naturally at 06:00-08:00 (awakening response +2.5-10 nmol/L increase); chronic stress flattens this rhythm, losing the morning immunosuppressive pulse
- NK cell cytotoxicity drops 40-50% during academic exam stress and remains suppressed for weeks afterward—clinical window for viral reactivation
- Anxiety disorders and hypochondriasis increase respiratory disease mortality by 23-88% through chronic sympathetic-mediated immune suppression despite absence of structural lung disease
- Glucocorticoid resistance develops when chronic stress phosphorylates GR at Ser226, impairing anti-inflammatory function while maintaining apoptotic (immunosuppressive) signaling
- Metabolic suppression: activated T cells require 20-40x baseline glucose; cortisol-induced insulin resistance starves T cells during chronic stress
- cortisol — primary glucocorticoid mediating immune suppression through GR-dependent transcriptional repression and T cell apoptosis induction
- HPA axis — chronic activation elevates sustained cortisol levels causing pathological immune suppression and eventual glucocorticoid resistance
- glucocorticoid resistance — paradoxical state where GR loses anti-inflammatory function but maintains immunosuppressive effects creating inflammation + vulnerability
- Selective resistance — specific form where cortisol resistance develops for inflammatory cytokine suppression while T cell suppression persists
- sympathetic nervous system — β2-adrenergic receptor activation on immune cells drives Th2 shift and NK cell suppression independent of cortisol pathway
- β2-adrenergic receptor — primary receptor mediating sympathetic immune suppression on lymphocytes, macrophages, and NK cells via cAMP-PKA-CREB
- T regulatory cells — mediate adaptive immune suppression through IL-10 and TGF-beta release; expand pathologically during chronic stress
- chronic stress — root cause of pathological immune suppression increasing infectious disease, cancer risk, vaccine hyporesponse, and viral reactivation
- sIgA — mucosal antibody reduced by sympathetic dominance; levels <25 mg/dL indicate compromised barrier immunity in gut and respiratory tract
- Th2 — antibody-mediated immunity favored during stress-induced suppression at expense of Th1 cellular immunity against viruses and cancer
- conditioned immunosuppression — demonstrates neural control of immunity; placebo/nocebo paired with immunosuppressant can reduce immunity 30-50% via learned pathways
- IL-10 — anti-inflammatory cytokine produced by Tregs and stress-activated macrophages that suppresses dendritic cell and T effector function
- TGF-beta — immunosuppressive cytokine from Tregs that inhibits T cell proliferation and induces anergy; elevated in chronic stress states
- GLUT1 — glucose transporter downregulated by cortisol-induced insulin resistance; suppression blocks T cell metabolic activation and clonal expansion
- anxiety — chronic activation of HPA axis and sympathetic nervous system causes immune suppression; increases respiratory mortality 23-88%
- vagus nerve — parasympathetic counterbalance to sympathetic immune suppression via cholinergic anti-inflammatory pathway; reduced vagal tone worsens suppression
- NK cells — natural killer cell cytotoxicity suppressed 40-50% by chronic stress through β2-adrenergic signaling; reduces cancer surveillance
- cancer — risk increases with chronic immune suppression due to reduced NK cell surveillance and CTL function allowing tumor immune evasion
- infections — frequency and severity increase with pathological immune suppression; viral reactivation (EBV, HSV) common during chronic stress
- Amylase — salivary marker of sympathetic activation; levels >60 U/mL indicate sympathetic dominance associated with immune suppression
- sexual activity — induces programmed Th2 shift in women enabling seminal tolerance; adaptive immune suppression for conception not pathological
- HRV — heart rate variability reflects vagal tone; low HRV (<50ms RMSSD) indicates sympathetic dominance and correlates with immune suppression
- metabolism — immune suppression includes metabolic component where cortisol-induced insulin resistance limits glucose to T cells blocking activation
- insulin resistance — chronic stress-induced metabolic dysfunction that secondarily suppresses immunity by restricting T cell glucose uptake
- Module 1: Introduction to cPNI, stress physiology, HPA axis
- Module 2: Immune system fundamentals, cytokine biology, stress-immune interactions
- Module 7: Clinical applications, saliva testing, intervention strategies